Geneva, Sept. 23 -- International Clinical Trials Registry received information related to the study (ISRCTN48917589) titled 'Testing a new AI tool to quickly identify MRSA and detect PVL genes to help improve treatment decisions' on Sept. 15.
Study Type: Interventional
Study Design:
Randomized controlled trial (Efficacy)
Primary Sponsor: Tri-Service General Hospital
Condition:
Antibiotic resistance
Infections and Infestations
Intervention:
Randomized comparison of artificial intelligence-clinical decision support system (AI-CDSS) use with standard diagnostic and prescribing practices for MRSA.
This randomized controlled trial compares two groups: one using the AI-CDSS and the other following standard diagnostic and treatment pa...